Bristol Myers Slashes Forecast on Tumbling Revlimid Sales
Cancer-fighting drugs Revlimid and Pomalyst drive a sales shortfall in the second quarter.
Source: marketwatch.com
Stay updated with breaking news from Daniel Acker Bloomberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cancer-fighting drugs Revlimid and Pomalyst drive a sales shortfall in the second quarter.
The CDC said Tuesday that illnesses have been reported in New York, New Jersey, Connecticut and Massachusetts.
U.S. property prices face 2.4% decline amid high mortgage rates.
U.S. property prices face 2.4% decline amid high mortgage rates.
Hi Burger! Hi Barbie!